Literature DB >> 11912265

Postdialytic rebound of serum phosphorus: pathogenetic and clinical insights.

Roberto Minutolo1, Vincenzo Bellizzi1, Mario Cioffi1, Carmela Iodice1, Paolo Giannattasio1, Michele Andreucci1, Vincenzo Terracciano1, Biagio R Di Iorio1, Giuseppe Conte1, Luca De Nicola1.   

Abstract

To gain insights into postdialytic rebound of serum phosphate (PDR-P), serum phosphate (P), calcium (Ca), and parathyroid hormone (PTH), levels were compared from the end of treatment (T0) to the subsequent 30 to 120 min and up to 68 hr in uremic patients who underwent with crossover modality a single session of two dialytic treatments characterized by different convective removal: standard hemodialysis (HD) and hemodiafiltration (HDF). In HDF, versus HD, P removal was greater (1171 +/- 90 versus 814 +/- 79 mg; P < 0.05) in the presence of similar predialytic P levels (6.0 +/- 0.2 and 5.9 +/- 0.4 mg/dl) and Kt/V (1.35 +/- 0.06 and 1.34 +/- 0.05); however, the serum P values at T0 did not differ (3.0 +/- 0.2 versus 3.3 +/- 0.2 mg/dl). In HDF, PDR-P was more rapid (30 min versus 90 min) and of a greater extent (at T120: +69 +/- 6% versus +31 +/- 4%; P < 0.0001). The higher P levels were maintained throughout the interdialytic period. Ca x P and PTH changed in parallel. Thereafter, patients were randomized to receive either HD or HDF for 3 mo. During this period, in the presence of similar Kt/V, protein intake, and dose of phospate binder, predialytic serum P levels diminished in HDF (from 5.8 +/- 0.2 to 4.4 +/- 0.3 mg/dl; P < 0.05), but they remained unchanged in HD. A similar pattern of changes was detected in Ca x P. Therefore, PDR-P is likely dependent on the mobilization of phosphate from a deep compartment induced by the intradialytic removal of this solute. Enhancement of convective removal acutely amplifies the entity of the phenomenon but allows a better control of Ca-P homeostasis in the medium term.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11912265     DOI: 10.1681/ASN.V1341046

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  15 in total

Review 1.  Artificial receptors for the recognition of phosphorylated molecules.

Authors:  Amanda E Hargrove; Sonia Nieto; Tianzhi Zhang; Jonathan L Sessler; Eric V Anslyn
Journal:  Chem Rev       Date:  2011-09-12       Impact factor: 60.622

2.  Survival of incident patients on high-volume online hemodiafiltration compared to low-volume online hemodiafiltration and high-flux hemodialysis.

Authors:  Goran Imamović; Rajko Hrvačević; Sonja Kapun; Daniele Marcelli; Inga Bayh; Aileen Grassmann; Laura Scatizzi; Jelena Maslovarić; Bernard Canaud
Journal:  Int Urol Nephrol       Date:  2013-09-21       Impact factor: 2.370

3.  Kinetic model of phosphorus mobilization during and after short and conventional hemodialysis.

Authors:  Baris U Agar; Alp Akonur; Ying-Cheng Lo; Alfred K Cheung; John K Leypoldt
Journal:  Clin J Am Soc Nephrol       Date:  2011-10-27       Impact factor: 8.237

4.  Effects of high-efficiency postdilution online hemodiafiltration and high-flux hemodialysis on serum phosphorus and cardiac structure and function in patients with end-stage renal disease.

Authors:  Rodríguez Castellanos Francisco; Meave Aloha; Paniagua Sierra Ramón
Journal:  Int Urol Nephrol       Date:  2012-11-10       Impact factor: 2.370

Review 5.  Phosphate balance in ESRD: diet, dialysis and binders against the low evident masked pool.

Authors:  A Galassi; A Cupisti; A Santoro; M Cozzolino
Journal:  J Nephrol       Date:  2014-09-23       Impact factor: 3.902

6.  EOS789, a broad-spectrum inhibitor of phosphate transport, is safe with an indication of efficacy in a phase 1b randomized crossover trial in hemodialysis patients.

Authors:  Kathleen M Hill Gallant; Elizabeth R Stremke; Laurie L Trevino; Ranjani N Moorthi; Simit Doshi; Meryl E Wastney; Nozomi Hisada; Jotaro Sato; Yoshitaka Ogita; Naohisa Fujii; Yuya Matsuda; Takei Kake; Sharon M Moe
Journal:  Kidney Int       Date:  2020-10-31       Impact factor: 10.612

7.  Phosphate overload accelerates vascular aging in uremic patients.

Authors:  Mario Cozzolino; Maurizio Gallieni; Andrea Galassi; Claudia Brambilla; Diego Brancaccio
Journal:  Heart Int       Date:  2006-05-28

8.  Haemocompatibility and ion exchange capability of nanocellulose polypyrrole membranes intended for blood purification.

Authors:  Natalia Ferraz; Daniel O Carlsson; Jaan Hong; Rolf Larsson; Bengt Fellström; Leif Nyholm; Maria Strømme; Albert Mihranyan
Journal:  J R Soc Interface       Date:  2012-02-01       Impact factor: 4.118

9.  Effect of increased convective clearance by on-line hemodiafiltration on all cause and cardiovascular mortality in chronic hemodialysis patients - the Dutch CONvective TRAnsport STudy (CONTRAST): rationale and design of a randomised controlled trial [ISRCTN38365125].

Authors:  E Lars Penne; Peter J Blankestijn; Michiel L Bots; Marinus A van den Dorpel; Muriel P Grooteman; Menso J Nubé; Ingeborg van der Tweel; Piet M Ter Wee
Journal:  Curr Control Trials Cardiovasc Med       Date:  2005-05-20

10.  Fluctuating plasma phosphorus level by changes in dietary phosphorus intake induces endothelial dysfunction.

Authors:  Eriko Watari; Yutaka Taketani; Tomoyo Kitamura; Terumi Tanaka; Hirokazu Ohminami; Maerjianghan Abuduli; Nagakatsu Harada; Hisami Yamanaka-Okumura; Hironori Yamamoto; Eiji Takeda
Journal:  J Clin Biochem Nutr       Date:  2014-12-16       Impact factor: 3.114

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.